You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

1021 Items
Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML)     
Intent: Curative
Drugs Used:
DAUNOrubicin,
cytarabine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
Drugs Used:
methotrexate,
cyclophosphamide,
cytarabine,
mercaptopurine,
asparaginase,
vinCRIStine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
Drugs Used:
vinCRIStine,
DOXOrubicin,
methotrexate,
dexamethasone,
asparaginase,
cyclophosphamide,
cytarabine,
thioguanine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
Drugs Used:
methotrexate,
vinCRIStine,
asparaginase
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
Drugs Used:
methotrexate,
vinCRIStine,
mercaptopurine,
prednisone
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Breast     
Intent: Palliative
Drugs Used:
abemaciclib (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Apr 2020
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
    anastrozole
... Show more tags
Drugs Used:
abemaciclib (Unfunded),
anastrozole
... Show more tags
Quick Link(s):
Regimen Monograph
May 2020
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
    fulvestrant
... Show more tags
Drugs Used:
abemaciclib (Unfunded),
fulvestrant
... Show more tags
Quick Link(s):
Regimen Monograph
Sep 2020
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
    letrozole
... Show more tags
Drugs Used:
abemaciclib (Unfunded),
letrozole
... Show more tags
Quick Link(s):
Regimen Monograph
May 2020
Cancer Type: Genitourinary, Prostate     
Intent: Palliative
Funding:
Exceptional Access Program
    abiraterone - Metastatic castrate-resistant prostate cancer, according to specific criteria
ODB - General Benefit
    dexamethasone
... Show more tags
Drugs Used:
abiraterone,
dexamethasone
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2021
Cancer Type: Genitourinary, Prostate     
Intent: Palliative
Funding:
Exceptional Access Program
    abiraterone - Metastatic castrate-resistant prostate cancer, according to specific criteria
ODB - General Benefit
    prednisone
... Show more tags
Drugs Used:
abiraterone (Unfunded),
prednisone
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2021
Cancer Type: Hematologic, Lymphoma - Hodgkin     
Intent: Curative
Drugs Used:
DOXOrubicin,
bleomycin,
vinBLAStine,
dacarbazine
... Show more tags
Quick Link(s):
Regimen Monograph
Jan 2021